Compounding Chemotherapy Market Report: Trends, Forecast and Competitive Analysis to 2031
Description
Compounding Chemotherapy Market Trends and Forecast
The future of the global compounding chemotherapy market looks promising with opportunities in the gravimetric automated compounding device and volumetric automated compounding device markets. The global compounding chemotherapy market is expected to grow with a CAGR of 6.4% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized cancer therapies, the rising prevalence of cancer, and the growing advancements in automated compounding technologies.
Emerging Trends in the Compounding Chemotherapy Market
The compounding chemotherapy market is undergoing transformative changes, propelled by a growing demand for tailored treatments and technological advancements. These emerging trends are enhancing the safety, precision, and efficiency of chemotherapy preparation, ultimately improving patient outcomes and expanding access to specialized care.
Recent Developments in the Compounding Chemotherapy Market
The compounding chemotherapy market has witnessed several crucial developments recently, driven by advancements in cancer treatment, increased regulatory focus on safety, and the persistent need for patient-specific drug formulations. These developments are enhancing both the quality and accessibility of compounded chemotherapy.
Strategic Growth Opportunities in the Compounding Chemotherapy Market
Strategic growth in the compounding chemotherapy market is highly dependent on addressing specific patient needs and leveraging technological advancements across key applications. Identifying these opportunities is crucial for market players to innovate and expand their services, ensuring high-quality, customized care for cancer patients.
Compounding Chemotherapy Market Driver and Challenges
The compounding chemotherapy market is influenced by a dynamic interplay of various technological, economic, and regulatory factors. Major drivers include the increasing prevalence of cancer and the growing demand for personalized treatments. However, significant challenges such as stringent regulatory compliance and the high costs associated with maintaining sterile environments continue to shape its trajectory.
The factors responsible for driving the compounding chemotherapy market include:
1. Increasing Cancer Incidence: The rising global incidence of various cancer types is a primary driver. As more individuals are diagnosed, the demand for chemotherapy treatments, including customized compounded formulations to meet specific patient needs, naturally escalates.
2. Growing Demand for Personalized Medicine: The shift towards personalized oncology, where treatments are tailored to a patient's unique genetic makeup and tumor characteristics, strongly drives the compounding market. Compounding pharmacies are essential for preparing these customized drug regimens.
3. Drug Shortages of Commercial Products: Frequent shortages of commercially manufactured chemotherapy drugs compel healthcare providers to rely on compounding pharmacies. This ensures continuity of care for patients whose lives depend on uninterrupted access to critical medications.
4. Advancements in Compounding Technology: Innovations in automated compounding systems, robotic technologies, and gravimetric/volumetric devices enhance accuracy, efficiency, and safety in preparation. These technological advancements drive the adoption of compounding services by reducing human error and improving quality.
5. Specific Patient Population Needs: Pediatric and geriatric cancer patients often require specialized dosages, alternative formulations (e.g., liquid forms), or allergen-free preparations not commercially available. Compounding addresses these unique needs, improving treatment adherence and outcomes for vulnerable groups.
Challenges in the compounding chemotherapy market are:
1. Stringent Regulatory Compliance: Compounding pharmacies face rigorous and evolving regulatory requirements (e.g., USP <797>, <800> in the US) to ensure sterility, quality, and safety. Adhering to these standards demands significant investment in facilities, equipment, and trained personnel, increasing operational complexity.
2. High Capital and Operating Costs: Establishing and maintaining state-of-the-art sterile compounding facilities, investing in expensive automated equipment, and managing specialized inventory incur substantial capital and ongoing operating costs. This financial burden can be a barrier for smaller compounding operations.
3. Quality Control and Consistency: Ensuring consistent quality, potency, and sterility across different batches of compounded chemotherapy drugs is a significant challenge. Variations in raw materials, processes, and human factors necessitate robust quality control measures and continuous monitoring to maintain patient safety.
The compounding chemotherapy market is robustly driven by the increasing need for individualized cancer treatments and the critical role it plays in addressing drug shortages. However, it must continuously navigate stringent regulatory landscapes, high operational costs, and the imperative for unwavering quality control to ensure safe and effective patient care.
List of Compounding Chemotherapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies compounding chemotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the compounding chemotherapy companies profiled in this report include-
The study includes a forecast for the global compounding chemotherapy market by technology, dose type, compounding type, delivery method, and region.
Compounding Chemotherapy Market by Technology [Value from 2019 to 2031]:
The compounding chemotherapy market is evolving rapidly, driven by the increasing need for personalized cancer treatments, drug shortages, and advancements in compounding technology. This specialized sector ensures patients receive customized dosages and formulations, significantly improving treatment efficacy and patient safety, especially for vulnerable populations like pediatric and geriatric patients.
Market Size Estimates: Compounding chemotherapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Compounding chemotherapy market size by various segments, such as by technology, dose type, compounding type, delivery method, and region in terms of value ($B).
Regional Analysis: Compounding chemotherapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, dose types, compounding types, delivery methods, and regions for the compounding chemotherapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the compounding chemotherapy market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the compounding chemotherapy market by technology (with robotic arm and without robotic arm), dose type (non-chemotherapeutic and chemotherapeutic), compounding type (pharmaceutical ingredient alteration, currently unavailable pharmaceutical manufacturing, and pharmaceutical dosage alteration), delivery method (gravimetric automated compounding device and volumetric automated compounding device), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.
The future of the global compounding chemotherapy market looks promising with opportunities in the gravimetric automated compounding device and volumetric automated compounding device markets. The global compounding chemotherapy market is expected to grow with a CAGR of 6.4% from 2025 to 2031. The major drivers for this market are the increasing demand for personalized cancer therapies, the rising prevalence of cancer, and the growing advancements in automated compounding technologies.
- Lucintel forecasts that, within the technology category, with robotic arm is expected to witness higher growth over the forecast period.
- Within the delivery method category, gravimetric automated compounding device is expected to witness higher growth.
- In terms of region, APAC is expected to witness the highest growth over the forecast period.
Emerging Trends in the Compounding Chemotherapy Market
The compounding chemotherapy market is undergoing transformative changes, propelled by a growing demand for tailored treatments and technological advancements. These emerging trends are enhancing the safety, precision, and efficiency of chemotherapy preparation, ultimately improving patient outcomes and expanding access to specialized care.
- Automation and Robotics in Compounding: The adoption of automated compounding devices and robotic systems is rapidly increasing. These technologies enhance accuracy, minimize human error, reduce staff exposure to hazardous drugs, and improve workflow efficiency in preparing chemotherapy formulations, leading to safer and more consistent medications.
- Emphasis on Personalized Medicine: There's a significant shift towards creating chemotherapy regimens tailored to individual patient needs, based on genetic profiles, cancer types, and treatment responses. Compounding pharmacies are crucial for this trend, allowing for precise dosing and customized drug combinations to optimize efficacy and minimize side effects.
- Enhanced Sterile Compounding Practices: Regulatory bodies and healthcare providers are placing a stronger emphasis on stringent sterile compounding guidelines and quality control measures. This trend ensures the aseptic preparation of chemotherapy drugs, critical for preventing infections in immunocompromised cancer patients and maintaining drug efficacy.
- Integration of Digital Health Solutions: Digital health, including telemedicine and mobile applications, is increasingly being integrated to facilitate patient management and adherence to compounded chemotherapy therapies. This offers better communication, remote monitoring, and improved coordination of care, especially for outpatient services.
- Focus on Drug Delivery Systems: Development of advanced drug delivery methods, such as nanoparticle-based formulations and liposomal encapsulation, is emerging. Compounding pharmacies are involved in preparing these specialized formulations, aiming to improve drug solubility, extend circulation, and enhance targeted delivery to tumor sites.
Recent Developments in the Compounding Chemotherapy Market
The compounding chemotherapy market has witnessed several crucial developments recently, driven by advancements in cancer treatment, increased regulatory focus on safety, and the persistent need for patient-specific drug formulations. These developments are enhancing both the quality and accessibility of compounded chemotherapy.
- Technological Advancements in Automation: A major development is the widespread adoption of automated compounding devices, including robotic arms. These systems significantly improve the accuracy and efficiency of chemotherapy preparation, reducing manual errors and safeguarding healthcare workers from hazardous drugs, ensuring consistent, high-quality output.
- Stricter Regulatory Oversight: Regulatory bodies globally are implementing more rigorous guidelines and standards for sterile compounding, particularly for chemotherapy drugs. This increased scrutiny aims to enhance patient safety by preventing contamination and ensuring the potency and stability of compounded medications, fostering compliance across the industry.
- Increased Demand for Personalized Therapies: The paradigm shift towards personalized medicine in oncology has profoundly impacted the compounding market. Compounding pharmacies are increasingly relied upon to create customized dosages and unique formulations for patients based on their specific genetic profiles and disease characteristics, optimizing treatment efficacy.
- Response to Drug Shortages: Compounding pharmacies play a critical role in mitigating drug shortages of commercially manufactured chemotherapy agents. Recent developments highlight their importance in ensuring continuity of care by preparing essential medications that are temporarily unavailable, thereby preventing treatment interruptions for cancer patients.
- Focus on Quality Control and Training: There's a growing emphasis on comprehensive quality control measures, including gravimetric analysis and sterility testing, alongside rigorous training programs for compounding pharmacists and technicians. This ensures adherence to best practices, minimizing risks and elevating the overall standard of compounded chemotherapy.
Strategic Growth Opportunities in the Compounding Chemotherapy Market
Strategic growth in the compounding chemotherapy market is highly dependent on addressing specific patient needs and leveraging technological advancements across key applications. Identifying these opportunities is crucial for market players to innovate and expand their services, ensuring high-quality, customized care for cancer patients.
- Personalized Dosing and Formulations: A significant growth opportunity lies in tailoring chemotherapy dosages and formulations to individual patient requirements, especially for pediatric, geriatric, or highly sensitive patients. This includes adjusting drug concentrations, creating alternative delivery forms (e.g., oral liquids), and combining therapies based on genomic profiles.
- Addressing Drug Shortages: Compounding pharmacies can strategically grow by consistently providing essential chemotherapy drugs that are in commercial shortage. Building reliable supply chains and robust compounding capabilities to fill these gaps ensures continuity of care for patients and positions these pharmacies as indispensable partners in oncology.
- Integration with Targeted Therapies and Immunotherapy: The increasing use of targeted therapies and immunotherapies presents a growth avenue. Compounding services can specialize in preparing these complex biological agents and their combinations, often requiring precise handling and individualized dosing, complementing standard treatment protocols.
- Outpatient and Homecare Compounding: Expanding compounding services for outpatient clinics and homecare settings offers a substantial opportunity. This caters to the growing trend of administering chemotherapy outside traditional hospital environments, requiring specialized preparation and delivery services that ensure patient comfort and safety.
- Technological Advancement Adoption: Investing in and adopting advanced compounding technologies like automated robotic systems, volumetric and gravimetric compounding devices, and integrated software platforms is a key growth strategy. These technologies enhance accuracy, improve sterile conditions, and increase efficiency, attracting more clients seeking high-quality services.
Compounding Chemotherapy Market Driver and Challenges
The compounding chemotherapy market is influenced by a dynamic interplay of various technological, economic, and regulatory factors. Major drivers include the increasing prevalence of cancer and the growing demand for personalized treatments. However, significant challenges such as stringent regulatory compliance and the high costs associated with maintaining sterile environments continue to shape its trajectory.
The factors responsible for driving the compounding chemotherapy market include:
1. Increasing Cancer Incidence: The rising global incidence of various cancer types is a primary driver. As more individuals are diagnosed, the demand for chemotherapy treatments, including customized compounded formulations to meet specific patient needs, naturally escalates.
2. Growing Demand for Personalized Medicine: The shift towards personalized oncology, where treatments are tailored to a patient's unique genetic makeup and tumor characteristics, strongly drives the compounding market. Compounding pharmacies are essential for preparing these customized drug regimens.
3. Drug Shortages of Commercial Products: Frequent shortages of commercially manufactured chemotherapy drugs compel healthcare providers to rely on compounding pharmacies. This ensures continuity of care for patients whose lives depend on uninterrupted access to critical medications.
4. Advancements in Compounding Technology: Innovations in automated compounding systems, robotic technologies, and gravimetric/volumetric devices enhance accuracy, efficiency, and safety in preparation. These technological advancements drive the adoption of compounding services by reducing human error and improving quality.
5. Specific Patient Population Needs: Pediatric and geriatric cancer patients often require specialized dosages, alternative formulations (e.g., liquid forms), or allergen-free preparations not commercially available. Compounding addresses these unique needs, improving treatment adherence and outcomes for vulnerable groups.
Challenges in the compounding chemotherapy market are:
1. Stringent Regulatory Compliance: Compounding pharmacies face rigorous and evolving regulatory requirements (e.g., USP <797>, <800> in the US) to ensure sterility, quality, and safety. Adhering to these standards demands significant investment in facilities, equipment, and trained personnel, increasing operational complexity.
2. High Capital and Operating Costs: Establishing and maintaining state-of-the-art sterile compounding facilities, investing in expensive automated equipment, and managing specialized inventory incur substantial capital and ongoing operating costs. This financial burden can be a barrier for smaller compounding operations.
3. Quality Control and Consistency: Ensuring consistent quality, potency, and sterility across different batches of compounded chemotherapy drugs is a significant challenge. Variations in raw materials, processes, and human factors necessitate robust quality control measures and continuous monitoring to maintain patient safety.
The compounding chemotherapy market is robustly driven by the increasing need for individualized cancer treatments and the critical role it plays in addressing drug shortages. However, it must continuously navigate stringent regulatory landscapes, high operational costs, and the imperative for unwavering quality control to ensure safe and effective patient care.
List of Compounding Chemotherapy Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies compounding chemotherapy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the compounding chemotherapy companies profiled in this report include-
- Biovalley Group
- Loccioni
- Simplivia
- Dedalus
- Grifols
- EQUASHIELD
- Kapsam Health Products
- ARxIUM
- Omnicel
- ATS Corporation
The study includes a forecast for the global compounding chemotherapy market by technology, dose type, compounding type, delivery method, and region.
Compounding Chemotherapy Market by Technology [Value from 2019 to 2031]:
- With Robotic Arm
- Without Robotic Arm
- Non-chemotherapeutic
- Chemotherapeutic
- North America
- Europe
- Asia Pacific
- The Rest of the World
The compounding chemotherapy market is evolving rapidly, driven by the increasing need for personalized cancer treatments, drug shortages, and advancements in compounding technology. This specialized sector ensures patients receive customized dosages and formulations, significantly improving treatment efficacy and patient safety, especially for vulnerable populations like pediatric and geriatric patients.
- United States: The U.S. market is witnessing heightened regulatory scrutiny and a strong push for enhanced sterile compounding practices to ensure patient safety. There's significant investment in automated compounding devices and robotic systems, improving accuracy and reducing human error in preparing complex chemotherapy formulations.
- China: China's compounding chemotherapy market is growing rapidly, propelled by government initiatives for personalized medicine and rising cancer incidence. Integration of AI and robotic arms in compounding processes is increasing, aiming to improve precision, efficiency, and reduce contamination risks in drug preparation.
- Germany: Germany emphasizes strict adherence to sterility standards and personalized medicine approaches in its compounding chemotherapy market. Advancements in automated compounding devices and cleanroom technologies are enhancing safety and accuracy, aligning with the country's well-established healthcare system and regulatory focus.
- India: India's market is expanding due to increasing cancer prevalence, growing demand for personalized therapy, and government support for improving cancer care. Technological advancements, particularly in automation and precision drug delivery, are gaining momentum to ensure quality and safety in compounded chemotherapy preparations.
- Japan: Japan's compounding chemotherapy market is focused on ensuring high-quality, patient-specific medications, driven by an aging population and advancements in personalized oncology. There's a growing emphasis on precision dosing and formulation adjustments to optimize treatment outcomes and minimize side effects for individual patients.
Market Size Estimates: Compounding chemotherapy market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Compounding chemotherapy market size by various segments, such as by technology, dose type, compounding type, delivery method, and region in terms of value ($B).
Regional Analysis: Compounding chemotherapy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, dose types, compounding types, delivery methods, and regions for the compounding chemotherapy market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the compounding chemotherapy market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the compounding chemotherapy market by technology (with robotic arm and without robotic arm), dose type (non-chemotherapeutic and chemotherapeutic), compounding type (pharmaceutical ingredient alteration, currently unavailable pharmaceutical manufacturing, and pharmaceutical dosage alteration), delivery method (gravimetric automated compounding device and volumetric automated compounding device), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.
Table of Contents
150 Pages
- 1. Executive Summary
- 2. Market Overview
- 2.1 Background and Classifications
- 2.2 Supply Chain
- 3. Market Trends & Forecast Analysis
- 3.1 Global Compounding Chemotherapy Market Trends and Forecast
- 3.2 Industry Drivers and Challenges
- 3.3 PESTLE Analysis
- 3.4 Patent Analysis
- 3.5 Regulatory Environment
- 4. Global Compounding Chemotherapy Market by Technology
- 4.1 Overview
- 4.2 Attractiveness Analysis by Technology
- 4.3 With Robotic Arm: Trends and Forecast (2019-2031)
- 4.4 Without Robotic Arm: Trends and Forecast (2019-2031)
- 5. Global Compounding Chemotherapy Market by Dose Type
- 5.1 Overview
- 5.2 Attractiveness Analysis by Dose Type
- 5.3 Non-chemotherapeutic: Trends and Forecast (2019-2031)
- 5.4 Chemotherapeutic: Trends and Forecast (2019-2031)
- 6. Global Compounding Chemotherapy Market by Compounding Type
- 6.1 Overview
- 6.2 Attractiveness Analysis by Compounding Type
- 6.3 Pharmaceutical Ingredient Alteration: Trends and Forecast (2019-2031)
- 6.4 Currently Unavailable Pharmaceutical Manufacturing: Trends and Forecast (2019-2031)
- 6.5 Pharmaceutical Dosage Alteration: Trends and Forecast (2019-2031)
- 7. Global Compounding Chemotherapy Market by Delivery Method
- 7.1 Overview
- 7.2 Attractiveness Analysis by Delivery Method
- 7.3 Gravimetric Automated Compounding Device: Trends and Forecast (2019-2031)
- 7.4 Volumetric Automated Compounding Device: Trends and Forecast (2019-2031)
- 8. Regional Analysis
- 8.1 Overview
- 8.2 Global Compounding Chemotherapy Market by Region
- 9. North American Compounding Chemotherapy Market
- 9.1 Overview
- 9.2 North American Compounding Chemotherapy Market by Technology
- 9.3 North American Compounding Chemotherapy Market by Delivery Method
- 9.4 United States Compounding Chemotherapy Market
- 9.5 Mexican Compounding Chemotherapy Market
- 9.6 Canadian Compounding Chemotherapy Market
- 10. European Compounding Chemotherapy Market
- 10.1 Overview
- 10.2 European Compounding Chemotherapy Market by Technology
- 10.3 European Compounding Chemotherapy Market by Delivery Method
- 10.4 German Compounding Chemotherapy Market
- 10.5 French Compounding Chemotherapy Market
- 10.6 Spanish Compounding Chemotherapy Market
- 10.7 Italian Compounding Chemotherapy Market
- 10.8 United Kingdom Compounding Chemotherapy Market
- 11. APAC Compounding Chemotherapy Market
- 11.1 Overview
- 11.2 APAC Compounding Chemotherapy Market by Technology
- 11.3 APAC Compounding Chemotherapy Market by Delivery Method
- 11.4 Japanese Compounding Chemotherapy Market
- 11.5 Indian Compounding Chemotherapy Market
- 11.6 Chinese Compounding Chemotherapy Market
- 11.7 South Korean Compounding Chemotherapy Market
- 11.8 Indonesian Compounding Chemotherapy Market
- 12. ROW Compounding Chemotherapy Market
- 12.1 Overview
- 12.2 ROW Compounding Chemotherapy Market by Technology
- 12.3 ROW Compounding Chemotherapy Market by Delivery Method
- 12.4 Middle Eastern Compounding Chemotherapy Market
- 12.5 South American Compounding Chemotherapy Market
- 12.6 African Compounding Chemotherapy Market
- 13. Competitor Analysis
- 13.1 Product Portfolio Analysis
- 13.2 Operational Integration
- 13.3 Porter’s Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
- 13.4 Market Share Analysis
- 14. Opportunities & Strategic Analysis
- 14.1 Value Chain Analysis
- 14.2 Growth Opportunity Analysis
- 14.2.1 Growth Opportunities by Technology
- 14.2.2 Growth Opportunities by Dose Type
- 14.2.3 Growth Opportunities by Compounding Type
- 14.2.4 Growth Opportunities by Delivery Method
- 14.3 Emerging Trends in the Global Compounding Chemotherapy Market
- 14.4 Strategic Analysis
- 14.4.1 New Product Development
- 14.4.2 Certification and Licensing
- 14.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures
- 15. Company Profiles of the Leading Players Across the Value Chain
- 15.1 Competitive Analysis
- 15.2 Biovalley Group
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.3 Loccioni
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.4 Simplivia
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.5 Dedalus
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.6 Grifols
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.7 EQUASHIELD
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.8 Kapsam Health Products
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.9 ARxIUM
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.10 Omnicel
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 15.11 ATS Corporation
- Company Overview
- Compounding Chemotherapy Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
- 16. Appendix
- 16.1 List of Figures
- 16.2 List of Tables
- 16.3 Research Methodology
- 16.4 Disclaimer
- 16.5 Copyright
- 16.6 Abbreviations and Technical Units
- 16.7 About Us
- 16.8 Contact Us
- List of Figures
- Chapter 1
- Figure 1.1: Trends and Forecast for the Global Compounding Chemotherapy Market
- Chapter 2
- Figure 2.1: Usage of Compounding Chemotherapy Market
- Figure 2.2: Classification of the Global Compounding Chemotherapy Market
- Figure 2.3: Supply Chain of the Global Compounding Chemotherapy Market
- Chapter 3
- Figure 3.1: Driver and Challenges of the Compounding Chemotherapy Market
- Figure 3.2: PESTLE Analysis
- Figure 3.3: Patent Analysis
- Figure 3.4: Regulatory Environment
- Chapter 4
- Figure 4.1: Global Compounding Chemotherapy Market by Technology in 2019, 2024, and 2031
- Figure 4.2: Trends of the Global Compounding Chemotherapy Market ($B) by Technology
- Figure 4.3: Forecast for the Global Compounding Chemotherapy Market ($B) by Technology
- Figure 4.4: Trends and Forecast for With Robotic Arm in the Global Compounding Chemotherapy Market (2019-2031)
- Figure 4.5: Trends and Forecast for Without Robotic Arm in the Global Compounding Chemotherapy Market (2019-2031)
- Chapter 5
- Figure 5.1: Global Compounding Chemotherapy Market by Dose Type in 2019, 2024, and 2031
- Figure 5.2: Trends of the Global Compounding Chemotherapy Market ($B) by Dose Type
- Figure 5.3: Forecast for the Global Compounding Chemotherapy Market ($B) by Dose Type
- Figure 5.4: Trends and Forecast for Non-chemotherapeutic in the Global Compounding Chemotherapy Market (2019-2031)
- Figure 5.5: Trends and Forecast for Chemotherapeutic in the Global Compounding Chemotherapy Market (2019-2031)
- Chapter 6
- Figure 6.1: Global Compounding Chemotherapy Market by Compounding Type in 2019, 2024, and 2031
- Figure 6.2: Trends of the Global Compounding Chemotherapy Market ($B) by Compounding Type
- Figure 6.3: Forecast for the Global Compounding Chemotherapy Market ($B) by Compounding Type
- Figure 6.4: Trends and Forecast for Pharmaceutical Ingredient Alteration in the Global Compounding Chemotherapy Market (2019-2031)
- Figure 6.5: Trends and Forecast for Currently Unavailable Pharmaceutical Manufacturing in the Global Compounding Chemotherapy Market (2019-2031)
- Figure 6.6: Trends and Forecast for Pharmaceutical Dosage Alteration in the Global Compounding Chemotherapy Market (2019-2031)
- Chapter 7
- Figure 7.1: Global Compounding Chemotherapy Market by Delivery Method in 2019, 2024, and 2031
- Figure 7.2: Trends of the Global Compounding Chemotherapy Market ($B) by Delivery Method
- Figure 7.3: Forecast for the Global Compounding Chemotherapy Market ($B) by Delivery Method
- Figure 7.4: Trends and Forecast for Gravimetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2019-2031)
- Figure 7.5: Trends and Forecast for Volumetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2019-2031)
- Chapter 8
- Figure 8.1: Trends of the Global Compounding Chemotherapy Market ($B) by Region (2019-2024)
- Figure 8.2: Forecast for the Global Compounding Chemotherapy Market ($B) by Region (2025-2031)
- Chapter 9
- Figure 9.1: North American Compounding Chemotherapy Market by Technology in 2019, 2024, and 2031
- Figure 9.2: Trends of the North American Compounding Chemotherapy Market ($B) by Technology (2019-2024)
- Figure 9.3: Forecast for the North American Compounding Chemotherapy Market ($B) by Technology (2025-2031)
- Figure 9.4: North American Compounding Chemotherapy Market by Delivery Method in 2019, 2024, and 2031
- Figure 9.5: Trends of the North American Compounding Chemotherapy Market ($B) by Delivery Method (2019-2024)
- Figure 9.6: Forecast for the North American Compounding Chemotherapy Market ($B) by Delivery Method (2025-2031)
- Figure 9.7: Trends and Forecast for the United States Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 9.8: Trends and Forecast for the Mexican Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 9.9: Trends and Forecast for the Canadian Compounding Chemotherapy Market ($B) (2019-2031)
- Chapter 10
- Figure 10.1: European Compounding Chemotherapy Market by Technology in 2019, 2024, and 2031
- Figure 10.2: Trends of the European Compounding Chemotherapy Market ($B) by Technology (2019-2024)
- Figure 10.3: Forecast for the European Compounding Chemotherapy Market ($B) by Technology (2025-2031)
- Figure 10.4: European Compounding Chemotherapy Market by Delivery Method in 2019, 2024, and 2031
- Figure 10.5: Trends of the European Compounding Chemotherapy Market ($B) by Delivery Method (2019-2024)
- Figure 10.6: Forecast for the European Compounding Chemotherapy Market ($B) by Delivery Method (2025-2031)
- Figure 10.7: Trends and Forecast for the German Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 10.8: Trends and Forecast for the French Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 10.9: Trends and Forecast for the Spanish Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 10.10: Trends and Forecast for the Italian Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 10.11: Trends and Forecast for the United Kingdom Compounding Chemotherapy Market ($B) (2019-2031)
- Chapter 11
- Figure 11.1: APAC Compounding Chemotherapy Market by Technology in 2019, 2024, and 2031
- Figure 11.2: Trends of the APAC Compounding Chemotherapy Market ($B) by Technology (2019-2024)
- Figure 11.3: Forecast for the APAC Compounding Chemotherapy Market ($B) by Technology (2025-2031)
- Figure 11.4: APAC Compounding Chemotherapy Market by Delivery Method in 2019, 2024, and 2031
- Figure 11.5: Trends of the APAC Compounding Chemotherapy Market ($B) by Delivery Method (2019-2024)
- Figure 11.6: Forecast for the APAC Compounding Chemotherapy Market ($B) by Delivery Method (2025-2031)
- Figure 11.7: Trends and Forecast for the Japanese Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 11.8: Trends and Forecast for the Indian Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 11.9: Trends and Forecast for the Chinese Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 11.10: Trends and Forecast for the South Korean Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 11.11: Trends and Forecast for the Indonesian Compounding Chemotherapy Market ($B) (2019-2031)
- Chapter 12
- Figure 12.1: ROW Compounding Chemotherapy Market by Technology in 2019, 2024, and 2031
- Figure 12.2: Trends of the ROW Compounding Chemotherapy Market ($B) by Technology (2019-2024)
- Figure 12.3: Forecast for the ROW Compounding Chemotherapy Market ($B) by Technology (2025-2031)
- Figure 12.4: ROW Compounding Chemotherapy Market by Delivery Method in 2019, 2024, and 2031
- Figure 12.5: Trends of the ROW Compounding Chemotherapy Market ($B) by Delivery Method (2019-2024)
- Figure 12.6: Forecast for the ROW Compounding Chemotherapy Market ($B) by Delivery Method (2025-2031)
- Figure 12.7: Trends and Forecast for the Middle Eastern Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 12.8: Trends and Forecast for the South American Compounding Chemotherapy Market ($B) (2019-2031)
- Figure 12.9: Trends and Forecast for the African Compounding Chemotherapy Market ($B) (2019-2031)
- Chapter 13
- Figure 13.1: Porter’s Five Forces Analysis of the Global Compounding Chemotherapy Market
- Figure 13.2: Market Share (%) of Top Players in the Global Compounding Chemotherapy Market (2024)
- Chapter 14
- Figure 14.1: Growth Opportunities for the Global Compounding Chemotherapy Market by Technology
- Figure 14.2: Growth Opportunities for the Global Compounding Chemotherapy Market by Dose Type
- Figure 14.3: Growth Opportunities for the Global Compounding Chemotherapy Market by Compounding Type
- Figure 14.4: Growth Opportunities for the Global Compounding Chemotherapy Market by Delivery Method
- Figure 14.5: Growth Opportunities for the Global Compounding Chemotherapy Market by Region
- Figure 14.6: Emerging Trends in the Global Compounding Chemotherapy Market
- List of Tables
- Chapter 1
- Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Compounding Chemotherapy Market by Technology, Dose Type, Compounding Type, and Delivery Method
- Table 1.2: Attractiveness Analysis for the Compounding Chemotherapy Market by Region
- Table 1.3: Global Compounding Chemotherapy Market Parameters and Attributes
- Chapter 3
- Table 3.1: Trends of the Global Compounding Chemotherapy Market (2019-2024)
- Table 3.2: Forecast for the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 4
- Table 4.1: Attractiveness Analysis for the Global Compounding Chemotherapy Market by Technology
- Table 4.2: Market Size and CAGR of Various Technology in the Global Compounding Chemotherapy Market (2019-2024)
- Table 4.3: Market Size and CAGR of Various Technology in the Global Compounding Chemotherapy Market (2025-2031)
- Table 4.4: Trends of With Robotic Arm in the Global Compounding Chemotherapy Market (2019-2024)
- Table 4.5: Forecast for With Robotic Arm in the Global Compounding Chemotherapy Market (2025-2031)
- Table 4.6: Trends of Without Robotic Arm in the Global Compounding Chemotherapy Market (2019-2024)
- Table 4.7: Forecast for Without Robotic Arm in the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 5
- Table 5.1: Attractiveness Analysis for the Global Compounding Chemotherapy Market by Dose Type
- Table 5.2: Market Size and CAGR of Various Dose Type in the Global Compounding Chemotherapy Market (2019-2024)
- Table 5.3: Market Size and CAGR of Various Dose Type in the Global Compounding Chemotherapy Market (2025-2031)
- Table 5.4: Trends of Non-chemotherapeutic in the Global Compounding Chemotherapy Market (2019-2024)
- Table 5.5: Forecast for Non-chemotherapeutic in the Global Compounding Chemotherapy Market (2025-2031)
- Table 5.6: Trends of Chemotherapeutic in the Global Compounding Chemotherapy Market (2019-2024)
- Table 5.7: Forecast for Chemotherapeutic in the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 6
- Table 6.1: Attractiveness Analysis for the Global Compounding Chemotherapy Market by Compounding Type
- Table 6.2: Market Size and CAGR of Various Compounding Type in the Global Compounding Chemotherapy Market (2019-2024)
- Table 6.3: Market Size and CAGR of Various Compounding Type in the Global Compounding Chemotherapy Market (2025-2031)
- Table 6.4: Trends of Pharmaceutical Ingredient Alteration in the Global Compounding Chemotherapy Market (2019-2024)
- Table 6.5: Forecast for Pharmaceutical Ingredient Alteration in the Global Compounding Chemotherapy Market (2025-2031)
- Table 6.6: Trends of Currently Unavailable Pharmaceutical Manufacturing in the Global Compounding Chemotherapy Market (2019-2024)
- Table 6.7: Forecast for Currently Unavailable Pharmaceutical Manufacturing in the Global Compounding Chemotherapy Market (2025-2031)
- Table 6.8: Trends of Pharmaceutical Dosage Alteration in the Global Compounding Chemotherapy Market (2019-2024)
- Table 6.9: Forecast for Pharmaceutical Dosage Alteration in the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 7
- Table 7.1: Attractiveness Analysis for the Global Compounding Chemotherapy Market by Delivery Method
- Table 7.2: Market Size and CAGR of Various Delivery Method in the Global Compounding Chemotherapy Market (2019-2024)
- Table 7.3: Market Size and CAGR of Various Delivery Method in the Global Compounding Chemotherapy Market (2025-2031)
- Table 7.4: Trends of Gravimetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2019-2024)
- Table 7.5: Forecast for Gravimetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2025-2031)
- Table 7.6: Trends of Volumetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2019-2024)
- Table 7.7: Forecast for Volumetric Automated Compounding Device in the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 8
- Table 8.1: Market Size and CAGR of Various Regions in the Global Compounding Chemotherapy Market (2019-2024)
- Table 8.2: Market Size and CAGR of Various Regions in the Global Compounding Chemotherapy Market (2025-2031)
- Chapter 9
- Table 9.1: Trends of the North American Compounding Chemotherapy Market (2019-2024)
- Table 9.2: Forecast for the North American Compounding Chemotherapy Market (2025-2031)
- Table 9.3: Market Size and CAGR of Various Technology in the North American Compounding Chemotherapy Market (2019-2024)
- Table 9.4: Market Size and CAGR of Various Technology in the North American Compounding Chemotherapy Market (2025-2031)
- Table 9.5: Market Size and CAGR of Various Delivery Method in the North American Compounding Chemotherapy Market (2019-2024)
- Table 9.6: Market Size and CAGR of Various Delivery Method in the North American Compounding Chemotherapy Market (2025-2031)
- Table 9.7: Trends and Forecast for the United States Compounding Chemotherapy Market (2019-2031)
- Table 9.8: Trends and Forecast for the Mexican Compounding Chemotherapy Market (2019-2031)
- Table 9.9: Trends and Forecast for the Canadian Compounding Chemotherapy Market (2019-2031)
- Chapter 10
- Table 10.1: Trends of the European Compounding Chemotherapy Market (2019-2024)
- Table 10.2: Forecast for the European Compounding Chemotherapy Market (2025-2031)
- Table 10.3: Market Size and CAGR of Various Technology in the European Compounding Chemotherapy Market (2019-2024)
- Table 10.4: Market Size and CAGR of Various Technology in the European Compounding Chemotherapy Market (2025-2031)
- Table 10.5: Market Size and CAGR of Various Delivery Method in the European Compounding Chemotherapy Market (2019-2024)
- Table 10.6: Market Size and CAGR of Various Delivery Method in the European Compounding Chemotherapy Market (2025-2031)
- Table 10.7: Trends and Forecast for the German Compounding Chemotherapy Market (2019-2031)
- Table 10.8: Trends and Forecast for the French Compounding Chemotherapy Market (2019-2031)
- Table 10.9: Trends and Forecast for the Spanish Compounding Chemotherapy Market (2019-2031)
- Table 10.10: Trends and Forecast for the Italian Compounding Chemotherapy Market (2019-2031)
- Table 10.11: Trends and Forecast for the United Kingdom Compounding Chemotherapy Market (2019-2031)
- Chapter 11
- Table 11.1: Trends of the APAC Compounding Chemotherapy Market (2019-2024)
- Table 11.2: Forecast for the APAC Compounding Chemotherapy Market (2025-2031)
- Table 11.3: Market Size and CAGR of Various Technology in the APAC Compounding Chemotherapy Market (2019-2024)
- Table 11.4: Market Size and CAGR of Various Technology in the APAC Compounding Chemotherapy Market (2025-2031)
- Table 11.5: Market Size and CAGR of Various Delivery Method in the APAC Compounding Chemotherapy Market (2019-2024)
- Table 11.6: Market Size and CAGR of Various Delivery Method in the APAC Compounding Chemotherapy Market (2025-2031)
- Table 11.7: Trends and Forecast for the Japanese Compounding Chemotherapy Market (2019-2031)
- Table 11.8: Trends and Forecast for the Indian Compounding Chemotherapy Market (2019-2031)
- Table 11.9: Trends and Forecast for the Chinese Compounding Chemotherapy Market (2019-2031)
- Table 11.10: Trends and Forecast for the South Korean Compounding Chemotherapy Market (2019-2031)
- Table 11.11: Trends and Forecast for the Indonesian Compounding Chemotherapy Market (2019-2031)
- Chapter 12
- Table 12.1: Trends of the ROW Compounding Chemotherapy Market (2019-2024)
- Table 12.2: Forecast for the ROW Compounding Chemotherapy Market (2025-2031)
- Table 12.3: Market Size and CAGR of Various Technology in the ROW Compounding Chemotherapy Market (2019-2024)
- Table 12.4: Market Size and CAGR of Various Technology in the ROW Compounding Chemotherapy Market (2025-2031)
- Table 12.5: Market Size and CAGR of Various Delivery Method in the ROW Compounding Chemotherapy Market (2019-2024)
- Table 12.6: Market Size and CAGR of Various Delivery Method in the ROW Compounding Chemotherapy Market (2025-2031)
- Table 12.7: Trends and Forecast for the Middle Eastern Compounding Chemotherapy Market (2019-2031)
- Table 12.8: Trends and Forecast for the South American Compounding Chemotherapy Market (2019-2031)
- Table 12.9: Trends and Forecast for the African Compounding Chemotherapy Market (2019-2031)
- Chapter 13
- Table 13.1: Product Mapping of Compounding Chemotherapy Suppliers Based on Segments
- Table 13.2: Operational Integration of Compounding Chemotherapy Manufacturers
- Table 13.3: Rankings of Suppliers Based on Compounding Chemotherapy Revenue
- Chapter 14
- Table 14.1: New Product Launches by Major Compounding Chemotherapy Producers (2019-2024)
- Table 14.2: Certification Acquired by Major Competitor in the Global Compounding Chemotherapy Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.